Antiphospholipid Antibodies Activate Vascular Endothelial Cells

Abstract

Antiphospholipid antibodies (aPL) are associated with a syndrome of arterial and venous thrombosis and recurrent fetal loss. We have shown that IgG purified from patients with aPL activate vascular endothelial cells (EC), converting the steady-state, non-thrombotic endothelial surface to a pro-thrombotic state. The aPL-activated EC are characterized by the expression of leukocyte adhesion molecules, including ICAM-1, VCAM, and E-selectin. EC activation is dependent upon the presence of β2-GP-I, a cofactor necessary for anticardiolipin reactivity. In addition, EC activation is not attributable to endotoxin contamination, Fc receptor interactions, or immune complexes, but rather is the result of the specific anticardiolipin reactivity of the IgG. Endothelial activation by aPL may be an important mechanism by which these antibodies cause a hypercoagulable state.

Keywords

antiphospholipid antibodies thrombosis endothelial cells

Get full access to this article

View all access options for this article.

References

Sammaritano

Gharavi

Lockshin

. Antiphospholipid antibody syndrome: immunologic and clinical aspects. Sem Arth and Rheum 1990; 20: 81–56

Nachman

Silverstein

. Hypercoagulable states. Ann Intern Med 1993; 119: 819–827

Bevilacqua

Interlukin-1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. J Clin Invest 1985; 76: 2003–2011

Nachman

Hajjar

Silverstein

Dinarello

Interleukin-1 induces endothelial cell synthesis of plasminogen activator inhibitor. J Exp Med 1986; 163: 1595–1600

Etingen

Silverstein

Friedman

Hajjar

. Viral activation of the coagulation cascade: Molecular interactions at the surface of infected endothelial cells. Cell 1990; 61: 657–662

Saadi

Platt

. Transient perturbation of endothelial integrity induced by natural antibodies and complement J Exp Med 1995; 181: 21–29

Simantov

Activation of cultured vascular endothelial cells by antiphospholipid antibodies. J Clin Invest 1995; 96: 2211–2219

McCrae

Detection of endothelial cell-reactive immunoglobulin in patients with anti-phospholipid antibodies. Br J Haematol 1991; 79: 595–605

Del Papa

Relationship between anti-phospholipid and antiendothelial cell antibodies: further characterization of the reactivity of resting and cytokine-activated endothelial cells. Clin and Exp Rheum 1992; 10: 37–42

10.

Hess

Shepard

Adams

. Increased immunoglobulin binding to cerebral endothelium in patients with antiphospholipid antibodies. Stroke 1993; 24: 994–599

11.

Gharavi

Sammaritano

Wen

Elkon

. Induction of antiphospholipid antibodies by immunization with (β₂-glycoprotein I (Apolipoprotein H). J Clin Invest 1992; 90: 1105–1109

12.

Cheung

Zheng

Silverstein

. Induction of monocyte tissue factor by adhesion to cytokine-activated endothelium. J Immunology 1995; 154: 4668–4777

13.

Huh

Yesner

Silverstein

. CD36 induction on human monocytes upon adhesion to TNF-activated endothelial cells. J Biol Chem 1996; 270: 6267–6271

14.

Del Papa

Characterization of anti-endothelial cell antibodies in antiphospholipid syndrome. In: Polli

(ed) Molecular Basis of Human Diseases. Elsevier Science Publishers: Amsterdam, 1993, 67–74